Executive summary of clinical practice guide on fracture risk in lifestyle diseases

from the Japan Osteoporosis Society Lifestyle diseases-related Fracture Risk Investigation Committee

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Accumulating evidence has shown that patients with lifestyle diseases such as type 2 diabetes mellitus, chronic kidney disease, and chronic obstructive pulmonary disease are at increased risk of osteoporotic fracture. Fractures deteriorate quality of life, activities of daily living, and mortality as well as a lifestyle disease. Therefore, preventing fracture is an important issue for those patients. Although the mechanism of the lifestyle diseases-induced bone fragility is still unclear, not only bone mineral density (BMD) reduction but also bone quality deterioration are involved in it. Because fracture predictive ability of BMD and FRAX® is limited, especially for patients with lifestyle diseases, the optimal management strategy should be established. Thus, when the intervention of the lifestyle diseases-induced bone fragility is initiated, the deterioration of bone quality should be taken into account. We here review the association between lifestyle diseases and fracture risk and proposed an algorism of starting anti-osteoporosis drugs for patients with lifestyle diseases.

Original languageEnglish
Pages (from-to)746-758
Number of pages13
JournalJournal of Bone and Mineral Metabolism
Volume38
Issue number6
DOIs
Publication statusPublished - 01-11-2020

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Fingerprint

Dive into the research topics of 'Executive summary of clinical practice guide on fracture risk in lifestyle diseases'. Together they form a unique fingerprint.

Cite this